rs1555452573
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_019109.5(ALG1):āc.1136T>Gā(p.Val379Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. V379V) has been classified as Uncertain significance.
Frequency
Consequence
NM_019109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG1 | NM_019109.5 | c.1136T>G | p.Val379Gly | missense_variant | 11/13 | ENST00000262374.10 | |
ALG1 | NM_001330504.2 | c.803T>G | p.Val268Gly | missense_variant | 11/13 | ||
ALG1 | XM_017023457.3 | c.1097T>G | p.Val366Gly | missense_variant | 10/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG1 | ENST00000262374.10 | c.1136T>G | p.Val379Gly | missense_variant | 11/13 | 1 | NM_019109.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459684Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726148
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
ALG1-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 11, 2016 | In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a ALG1-related disease. This sequence change replaces valine with glycine at codon 379 of the ALG1 protein (p.Val379Gly). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glycine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at